Current treatment of nasopharyngeal carcinoma

European Journal of Cancer

Volumn 47, Issue SUPPL. 3, 2011, Pages

  Chan, Anthony T C ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOPLATIN; CETUXIMAB; CISPLATIN; FLUOROURACIL;

ADJUVANT CHEMOTHERAPY; ARTICLE; CANCER RADIOTHERAPY; CANCER SURVIVAL; CHEMOTHERAPY RADIOTHERAPY; DRUG TOLERABILITY; HUMAN; INTENSITY MODULATED RADIATION THERAPY; NASOPHARYNX CARCINOMA; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL;

EID: 80053268380     PISSN: 09598049     EISSN: 18790852     Source Type: Journal    
DOI: 10.1016/S0959-8049(11)70179-4     Document Type: Article

References (23)

1. AW Lee, WM Sze, JS Au et al. Treatment results for nasopharyngeal carcinoma in the modern era: the Hong Kong experience Int J Radiat Oncol Biol Phys 61 2005 1107 1116 (Pubitemid 40340904)
2. EH Pow, DL Kwong, AS McMillan et al. Xerostomia and quality of life after intensity-modulated radiotherapy vs. conventional radiotherapy for early-stage nasopharyngeal carcinoma: Initial report on a randomized controlled clinical trial Int J Radiat Oncol Biol Phys 66 2006 981 991 (Pubitemid 44633504)
3. MK Kam, SF Leung, B Zee et al. Prospective randomized study of intensity-modulated radiotherapy on salivary gland function in early-stage nasopharyngeal carcinoma patients J Clin Oncol 25 2007 4873 4879 (Pubitemid 350220416)
4. SH Cheng, SYC Tsai, KL Yen et al. Concomitant radiotherapy and chemotherapy for early-stage nasopharyngeal carcinoma J Clin Oncol 18 2000 2040 2045 (Pubitemid 30324356)
5. DT Chua, J Ma, JS Sham et al. Improvement of survival after addition of induction chemotherapy to radiotherapy in patients with early-stage nasopharyngeal carcinoma: Subgroup analysis of two Phase III trials Int J Radiat Oncol Biol Phys 65 2006 1300 1306 (Pubitemid 44425202)
6. AT Chan, V Gregoive, JL Legebvre, L Licitra, E Felip Nasopharyngeal cancer: EHNS-ESMO-ESTRO Clinical Practice Guidelines Ann Oncol 21 55 2010 vl87 vl89
7. B Baujat, H Audry, J Bourhis et al. Chemotherapy in locally advanced nasopharyngeal carcinoma: An individual patient data meta-analysis of eight randomized trials and 1753 patients Int J Radiat Oncol Biol Phys 64 2006 47 56 (Pubitemid 41831208)
8. M Al-Sarraf, M LeBlanc, PG Giri et al. Chemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer: Phase III randomized intergroup study 0099 J Clin Oncol 16 1998 1310 1317 (Pubitemid 28175745)
9. AT Chan, SF Leung, RKC Ngan et al. Overall survival after concurrent cisplatin-radiotherapy compared with radiotherapy alone in locoregionally advanced nasopharyngeal carcinoma JNatl Cancer Inst 97 2005 536 539 (Pubitemid 40590436)
10. KH Chi, YC Chang, WY Guo et al. A phase III study of adjuvant chemotherapy in advanced nasopharyngeal carcinoma patients Int J Radiat Oncol Biol Phys 52 2002 1238 1244
11. Preliminary results of a randomized trial comparing neoadjuvant chemotherapy (cisplatin, epirubicin, bleomycin) plus radiotherapy vs radiotherapy alone in stage IV (>or = N2, M0) undifferentiated nasopharyngeal carcinoma: a positive effect on progression-free survival. International Nasopharynx Cancer Study Group. VUMCA I trial Int J Radiat Oncol Biol Phys 35 1996 463 469
12. J Ma, HQ Mai, MH Hong et al. Results of a prospective randomized trial comparing neoadjuvant chemotherapy plus radiotherapy with radiotherapy alone in patients with locoregionally advanced nasopharyngeal carcinoma J Clin Oncol 19 2001 1350 1357 (Pubitemid 32202540)
13. D Rischin, J Corry, J Smith et al. Excellent disease control and survival in patients with advanced nasopharyngeal cancer treated with chemoradiation J Clin Oncol 20 2002 1845 1852 (Pubitemid 34273275)
14. AT Chan, BB Ma, YM Lo et al. Phase II study of neoadjuvant carboplatin and paclitaxel followed by radiotherapy and concurrent cisplatin in patients with locoregionally advanced nasopharyngeal carcinoma: Therapeutic monitoring with plasma epstein-barr virus DNA J Clin Oncol 22 2004 3053 3060 (Pubitemid 41103717)
15. EP Hui, BB Ma, SF Leung et al. Randomized phase II trial of concurrent cisplatin-radiotherapy with or without neoadjuvant docetaxel and cisplatin in advanced nasopharyngeal carcinoma JClin Oncol 27 2009 242 249
16. EP Hui, SF Leung, JS Au et al. Lung metastasis alone in nasopharyngeal carcinoma: a relatively favorable prognostic group. A study by the Hong Kong Nasopharyngeal Carcinoma Study Group Cancer 101 2004 300 306 (Pubitemid 38890833)
17. AT Chan, MM Hsu, BC Goh et al. Multicenter, phase II study of cetuximab in combination with carboplatin in patients with recurrent or metastatic nasopharyngeal carcinoma J Clin Oncol 23 2005 3568 3576
18. AT Chan, Q Tao, KD Robertson et al. Azacitidine induces demethylation of the Epstein-Barr virus genome in tumors JClin Oncol 22 8 2004 1373 1381 (Pubitemid 41103618)
19. YM Lo, LY Chan, KW Lo et al. Quantitative analysis of cell-free Epstein-Barr virus DNA in plasma of patients with nasopharyngeal carcinoma Cancer Res 59 1999 1188 1191 (Pubitemid 29136244)
20. SF Leung, B Zee, BB Ma et al. Plasma Epstein-Barr viral deoxyribonucleic acid quantitation complements tumor-node-metastasis staging prognostication in nasopharyngeal carcinoma JClin Oncol 24 2006 5414 5418 (Pubitemid 46623174)
21. AT Chan, YM Lo, B Zee et al. Plasma Epstein-Barr virus DNA and residual disease after radiotherapy for undifferentiated nasopharyngeal carcinoma J Nati Cancer Inst 94 2002 1614 1619 (Pubitemid 35378726)
22. JC Lin, WY Wang, KY Chen et al. Quantification of plasma Epstein-Barr virus DNA in patients with advanced nasopharyngeal carcinoma N Engl JMed 350 2004 2461 2470 (Pubitemid 38736543)
23. CL Lin, WF Lo, TH Lee et al. Immunization with Epstein-Barr Virus (EBV) peptide-pulsed dendritic cells induces functional CD8+ T-cell immunity and may lead to tumor regression in patients with EBV-positive nasopharyngeal carcinoma Cancer Res 62 23 2002 6952 6958